Shivers

Shivers

Trading
15,532 Views
Shivers Media, LLC was created for the purpose of developing software which uses the internet and blockchain technology to deliver horror films. Along with our distribution platform, we are also using our token sale to create a fund for creating a slate of unique and exclusive horror films as a way to attract users to our platform.
General
Website: Visit
White paper: Read
ICO Time: 01 Jan 2018 - 28 Feb 2018
Country: USA
Token info
Ticker: SHVR
Platform: Ethereum
Token Type: ERC20
Available for sale: 160,000,000 SHVR (80%)
Total supply: 200,000,000 SHVR
Financial
ICO Price: β‰ˆ 0.685 USD
Accepting: ETH
Hard cap: 178000 ETH
November 2017
Initial Legal Formation
November 2017
Industry Partnerships
December 2017
Private Sale
January 2018
Pre-Sale
Februrary 2018
Token Sale
March 2018 - Continuous
Software Development
March 2018
Initial Film Production
July 2018
Beta Release (Software)
July 2018
Initial Film Releases
August 2018
Public Release (Software/Film)
Dar Warison
Founder
Participates in a number of projects
Daton Pope
Founder
Participates in a number of projects
Eduardo Sanchez
Advisor, CO-creator of The Blair Witch Project
Participates in a number of projects
Gregg Hale
Advisor, Producer of The Blair Witch Project
Participates in a number of projects
Benjamin Sacks
Producer
Participates in a number of projects
Samuel Gauvin
Promotions - Infamous Horror
Participates in a number of projects
Amber Hartley
Advisor - Burstiq
Participates in a number of projects

Advisors (0)

ICO List
Other Interesting ICOs
Upcoming
Beyond Seen Screen
Beyond Seen Screen has created a platform that enables interactivity with video content. With Beyond Seen Screen watching video content is no longer a passive action, a one-way street. The platform enables content producers and content distribution companies to link additional information to the video content. Viewers will no longer only passively receive adverts, trailers and other video content but will have ability to interactively engage with them by using their mobile device.
Pre-Sale
NOBAR
Forget fragmented marketplaces! NOBAR is creating the first ever "Unified Crypto Commerce" to provide a holistic solution to the purchasing problem with cryptocurrency and crypto token. Our two robust functions - "Crypto Commerce" and "Shop-App" will facilitate all possible commercial activities.
Upcoming
Universal Recognition Token
Universal Recognition Token is the first blockchain-based corporate rewards marketplace where employees may sell and auction their gifts, rewards and prizes to the general public. URT is disrupting a $90 billion dollar annual spend market in the United States alone, according to the Incentive Federation.
Upcoming
DATA
DATA is a blockchain project initiated and governed by Blockchain Data Foundation Limited ("Blockchain Data Foundation", or BDF from hereafter), a company limited by guarantee to be incorporated in Singapore and governed in a not-for-profit manner. This project is being developed in collaboration with Yomob International Co., Ltd. ("Yomob"), a mobile monetization-as-a-service company.
Upcoming
Artcoin
The art world is traditionally anything but transparent, and that’s where ArtCoin, an investor-driven collective, creates real change for investors. Guiding users through transactions using cryptocurrencies, ArtCoin enables investors to benefit from the increased security and transparency of the Smart Contracts platforms. By pulling together information that everyday investors normally can’t access, ArtCoin democratizes the art market and acts as a direct liaison between investors and the art industry.
Upcoming
MediLOT
MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.